| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Aberrant protein synthesis and cancer development: The role of canonical eukaryotic initiation, elongation and termination factors in tumorigenesis
|
Rubio, Angela
|
|
|
86 |
P3 |
p. 151-165
|
article
|
| 2 |
A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma
|
Pandya, Gouri
|
|
|
86 |
P3 |
p. 682-692
|
article
|
| 3 |
Anticancer activity of lactic acid bacteria
|
Garbacz, Katarzyna
|
|
|
86 |
P3 |
p. 356-366
|
article
|
| 4 |
Anticancer natural products targeting immune checkpoint protein network
|
Chun, Kyung-Soo
|
|
|
86 |
P3 |
p. 1008-1032
|
article
|
| 5 |
Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation
|
Motofei, Ion G.
|
|
|
86 |
P3 |
p. 600-615
|
article
|
| 6 |
Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation
|
Queen, Aarfa
|
|
|
86 |
P3 |
p. 899-913
|
article
|
| 7 |
Carcinogenic microbiota and its role in colorectal cancer development
|
Karpiński, Tomasz M.
|
|
|
86 |
P3 |
p. 420-430
|
article
|
| 8 |
Characterizing and exploiting the many roles of aberrant H2B monoubiquitination in cancer pathogenesis
|
Jeusset, Lucile M.
|
|
|
86 |
P3 |
p. 782-798
|
article
|
| 9 |
Checkpoint: Inspecting the barriers in glioblastoma immunotherapies
|
Preddy, Isabelle
|
|
|
86 |
P3 |
p. 473-481
|
article
|
| 10 |
Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes?
|
Ahmad, Mudassier
|
|
|
86 |
P3 |
p. 1175-1185
|
article
|
| 11 |
Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis
|
Mughees, Mohd
|
|
|
86 |
P3 |
p. 497-512
|
article
|
| 12 |
Chemokines in colon cancer progression
|
Jia, Sheng-Nan
|
|
|
86 |
P3 |
p. 400-407
|
article
|
| 13 |
Chemokines network in bone metastasis: Vital regulators of seeding and soiling
|
Sharma, Gunjan
|
|
|
86 |
P3 |
p. 457-472
|
article
|
| 14 |
Chemotherapy as a regulator of extracellular matrix-cell communication: Implications in therapy resistance
|
Gonzalez-Molina, Jordi
|
|
|
86 |
P3 |
p. 224-236
|
article
|
| 15 |
Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1
|
Nagaraju, Ganji Purnachandra
|
|
|
86 |
P3 |
p. 616-621
|
article
|
| 16 |
Cooperation and competition by RNA-binding proteins in cancer
|
Nag, Sharanya
|
|
|
86 |
P3 |
p. 286-297
|
article
|
| 17 |
Cytotoxic activity of l-lysine alpha-oxidase against leukemia cells
|
Costa, Mariana N.
|
|
|
86 |
P3 |
p. 590-599
|
article
|
| 18 |
Deregulated transcription factors and poor clinical outcomes in cancer patients
|
Li, Yiwei
|
|
|
86 |
P3 |
p. 122-134
|
article
|
| 19 |
Deregulated transcription factors in cancer cell metabolisms and reprogramming
|
Kant, Rajni
|
|
|
86 |
P3 |
p. 1158-1174
|
article
|
| 20 |
Disrupting cancer angiogenesis and immune checkpoint networks for improved tumor immunity
|
Anderson, Trevor S.
|
|
|
86 |
P3 |
p. 981-996
|
article
|
| 21 |
Dysregulated FOXM1 signaling in the regulation of cancer stem cells
|
Sher, Gulab
|
|
|
86 |
P3 |
p. 107-121
|
article
|
| 22 |
Editorial Board
|
|
|
|
86 |
P3 |
p. ii
|
article
|
| 23 |
Epigenetics in hepatocellular carcinoma
|
Nagaraju, Ganji Purnachandra
|
|
|
86 |
P3 |
p. 622-632
|
article
|
| 24 |
Evolution of small cell lung cancer tumor mutation: from molecular mechanisms to novel viewpoints
|
Guan, Xiaojiao
|
|
|
86 |
P3 |
p. 346-355
|
article
|
| 25 |
Evolving role of immunotherapy in small cell lung cancer
|
Barrows, Elizabeth D.
|
|
|
86 |
P3 |
p. 868-874
|
article
|
| 26 |
Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC
|
Niu, Xing
|
|
|
86 |
P3 |
p. 273-285
|
article
|
| 27 |
Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging
|
Peltier, Agathe
|
|
|
86 |
P3 |
p. 262-272
|
article
|
| 28 |
Focus on organoids: cooperation and interconnection with extracellular vesicles – Is this the future of in vitro modeling?
|
Jurj, Ancuta
|
|
|
86 |
P3 |
p. 367-381
|
article
|
| 29 |
Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data
|
Harkus, Uasim
|
|
|
86 |
P3 |
p. 799-815
|
article
|
| 30 |
Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy
|
Gaikwad, Shreyas
|
|
|
86 |
P3 |
p. 137-150
|
article
|
| 31 |
Insights into the role of complement regulatory proteins in HPV mediated cervical carcinogenesis
|
Khan, Asiya
|
|
|
86 |
P3 |
p. 583-589
|
article
|
| 32 |
Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective
|
Panebianco, Concetta
|
|
|
86 |
P3 |
p. 997-1007
|
article
|
| 33 |
Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches
|
Shaath, Hibah
|
|
|
86 |
P3 |
p. 325-345
|
article
|
| 34 |
Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer
|
Wang, Yi
|
|
|
86 |
P3 |
p. 542-565
|
article
|
| 35 |
Metabolic reservoir cycles in cancer
|
Zhang, Cissy
|
|
|
86 |
P3 |
p. 180-188
|
article
|
| 36 |
Microbe-based therapies for colorectal cancer: Advantages and limitations
|
Saeed, Mohd
|
|
|
86 |
P3 |
p. 652-665
|
article
|
| 37 |
Microbes-mediated synthesis strategies of metal nanoparticles and their potential role in cancer therapeutics
|
Khalil, Ali Talha
|
|
|
86 |
P3 |
p. 693-705
|
article
|
| 38 |
Microbial cancer therapeutics: A promising approach
|
Diwan, Deepti
|
|
|
86 |
P3 |
p. 931-950
|
article
|
| 39 |
Microbial dysbiosis and epigenetics modulation in cancer development – A chemopreventive approach
|
Haque, Shafiul
|
|
|
86 |
P3 |
p. 666-681
|
article
|
| 40 |
Microbial polysaccharides: An emerging family of natural biomaterials for cancer therapy and diagnostics
|
Prateeksha,
|
|
|
86 |
P3 |
p. 706-731
|
article
|
| 41 |
Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy
|
Khan, Faizan Haider
|
|
|
86 |
P3 |
p. 732-742
|
article
|
| 42 |
Microbiota and gastric cancer
|
Bessède, Emilie
|
|
|
86 |
P3 |
p. 11-17
|
article
|
| 43 |
Microbiota and lung cancer
|
Goto, Taichiro
|
|
|
86 |
P3 |
p. 1-10
|
article
|
| 44 |
Microbiota and prostate cancer
|
Rizzo, Alessandro
|
|
|
86 |
P3 |
p. 1058-1065
|
article
|
| 45 |
Modulation and function of Pumilio proteins in cancer
|
Silva, Isabelle Leticia Zaboroski
|
|
|
86 |
P3 |
p. 298-309
|
article
|
| 46 |
Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment
|
Schoutrop, Esther
|
|
|
86 |
P3 |
p. 207-223
|
article
|
| 47 |
Molecular mechanisms underlying the development of neuroendocrine prostate cancer
|
Liu, Shiqin
|
|
|
86 |
P3 |
p. 57-68
|
article
|
| 48 |
Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
|
Patil, Kalyani
|
|
|
86 |
P3 |
p. 382-399
|
article
|
| 49 |
Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer
|
Zeng, Yongji
|
|
|
86 |
P3 |
p. 566-582
|
article
|
| 50 |
Multifaceted role of chemokines in solid tumors: From biology to therapy
|
Raza, Sana
|
|
|
86 |
P3 |
p. 1105-1121
|
article
|
| 51 |
Nanotherapeutics for immune network modulation in tumor microenvironments
|
Lee, Jaiwoo
|
|
|
86 |
P3 |
p. 1066-1087
|
article
|
| 52 |
Necroptosis pathways in tumorigenesis
|
Zhang, Tao
|
|
|
86 |
P3 |
p. 32-40
|
article
|
| 53 |
Non-coding genome in small cell lung cancer between theoretical view and clinical applications
|
Yin, Xiaomeng
|
|
|
86 |
P3 |
p. 237-250
|
article
|
| 54 |
Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme
|
Kazemi Shariat Panahi, Hamed
|
|
|
86 |
P3 |
p. 1122-1142
|
article
|
| 55 |
Optimal timing of PD-1 blockade in combination with oncolytic virus therapy
|
Nguyen, Hong-My
|
|
|
86 |
P3 |
p. 971-980
|
article
|
| 56 |
Pivotal role of PD-1/PD-L1 immune checkpoints in immune escape and cancer progression: Their interplay with platelets and FOXP3+Tregs related molecules, clinical implications and combinational potential with phytochemicals
|
Lee, Dae Young
|
|
|
86 |
P3 |
p. 1033-1057
|
article
|
| 57 |
Promalignant effects of antiangiogenics in the tumor microenvironment
|
Peix, Felix
|
|
|
86 |
P3 |
p. 199-206
|
article
|
| 58 |
Prospects of microbial-engineering for the production of graphene and its derivatives: Application to design nanosystms for cancer theranostics
|
Singh, Rajeev
|
|
|
86 |
P3 |
p. 885-898
|
article
|
| 59 |
Radiotherapy-induced remodeling of the tumor microenvironment by stromal cells
|
Berg, Tracy J.
|
|
|
86 |
P3 |
p. 846-856
|
article
|
| 60 |
Recent advances in microbial toxin-related strategies to combat cancer
|
Sharma, Prabodh Chander
|
|
|
86 |
P3 |
p. 753-768
|
article
|
| 61 |
Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways
|
Therachiyil, Lubna
|
|
|
86 |
P3 |
p. 1186-1202
|
article
|
| 62 |
Resistance to immune checkpoint blockade: Mechanisms, counter-acting approaches, and future directions
|
Haddad, Alexander F.
|
|
|
86 |
P3 |
p. 532-541
|
article
|
| 63 |
Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications
|
Maurya, Shailendra Kumar
|
|
|
86 |
P3 |
p. 914-930
|
article
|
| 64 |
RNA-binding proteins: Underestimated contributors in tumorigenesis
|
Zhao, Y.
|
|
|
86 |
P3 |
p. 431-444
|
article
|
| 65 |
Roles of RNA-binding proteins in immune diseases and cancer
|
Hashimoto, Shigeru
|
|
|
86 |
P3 |
p. 310-324
|
article
|
| 66 |
Senescence and the tumor-immune landscape: Implications for cancer immunotherapy
|
Chibaya, Loretah
|
|
|
86 |
P3 |
p. 827-845
|
article
|
| 67 |
Sex dimorphism in the tumor microenvironment – From bench to bedside and back
|
He, Fei
|
|
|
86 |
P3 |
p. 166-179
|
article
|
| 68 |
Small secretory proteins of immune cells can modulate gynecological cancers
|
Kumar, Niranjan
|
|
|
86 |
P3 |
p. 513-531
|
article
|
| 69 |
Special issue Microbes in Cancer Research in 'Seminar in Cancer Biology' 2021
|
Kalia, Vipin Chandra
|
|
|
86 |
P3 |
p. 1102-1104
|
article
|
| 70 |
STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges
|
Wong, Grace L.
|
|
|
86 |
P3 |
p. 84-106
|
article
|
| 71 |
Surgery-mediated tumor-promoting effects on the immune microenvironment
|
Cheng, Xiang
|
|
|
86 |
P3 |
p. 408-419
|
article
|
| 72 |
Targeting lactate-related cell cycle activities for cancer therapy
|
Lin, Jia
|
|
|
86 |
P3 |
p. 1231-1243
|
article
|
| 73 |
Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer
|
Luo, Hao
|
|
|
86 |
P3 |
p. 960-970
|
article
|
| 74 |
Targeting the “undruggable”: RNA-binding proteins in the spotlight in cancer therapy
|
Mir, C.
|
|
|
86 |
P3 |
p. 69-83
|
article
|
| 75 |
The altered lipidome of hepatocellular carcinoma
|
Tan, Shawn Lu Wen
|
|
|
86 |
P3 |
p. 445-456
|
article
|
| 76 |
The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer
|
Ramesh-Kumar, Deepthi
|
|
|
86 |
P3 |
p. 18-31
|
article
|
| 77 |
The impact of VEGF on cancer metastasis and systemic disease
|
Yang, Yunlong
|
|
|
86 |
P3 |
p. 251-261
|
article
|
| 78 |
The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis
|
Navashenaq, Jamshid Gholizadeh
|
|
|
86 |
P3 |
p. 951-959
|
article
|
| 79 |
The oral microbiota and its role in carcinogenesis
|
Stasiewicz, Mark
|
|
|
86 |
P3 |
p. 633-642
|
article
|
| 80 |
The radiobiology of TGFβ
|
Barcellos-Hoff, Mary Helen
|
|
|
86 |
P3 |
p. 857-867
|
article
|
| 81 |
Therapy-induced modulation of extracellular vesicles in hepatocellular carcinoma
|
Yeung, Cherlie Lot Sum
|
|
|
86 |
P3 |
p. 1088-1101
|
article
|
| 82 |
Therapy-induced shaping of the glioblastoma microenvironment: Macrophages at play
|
Erbani, Johanna
|
|
|
86 |
P3 |
p. 41-56
|
article
|
| 83 |
The role of RNA-binding proteins in the processing of mRNAs produced by carcinogenic papillomaviruses
|
Kajitani, Naoko
|
|
|
86 |
P3 |
p. 482-496
|
article
|
| 84 |
The role of transcription factors in the acquisition of the four latest proposed hallmarks of cancer and corresponding enabling characteristics
|
Morgan, Maria P.
|
|
|
86 |
P3 |
p. 1203-1215
|
article
|
| 85 |
Tumor glycolysis, an essential sweet tooth of tumor cells
|
Paul, Sumana
|
|
|
86 |
P3 |
p. 1216-1230
|
article
|
| 86 |
Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies
|
Liu, Hanxin
|
|
|
86 |
P3 |
p. 769-781
|
article
|
| 87 |
Understanding RNA-binding proteins
|
LLeonart, Matilde E.
|
|
|
86 |
P3 |
p. 135-136
|
article
|
| 88 |
Understanding the cross-talk between human microbiota and gastrointestinal cancer for developing potential diagnostic and prognostic biomarkers
|
Kashyap, Sheetal
|
|
|
86 |
P3 |
p. 643-651
|
article
|
| 89 |
Urinary microbiota and bladder cancer: A systematic review and a focus on uropathogens
|
Yacouba, Abdourahamane
|
|
|
86 |
P3 |
p. 875-884
|
article
|
| 90 |
Vaginal microbiome and cervical cancer
|
Kyrgiou, Maria
|
|
|
86 |
P3 |
p. 189-198
|
article
|
| 91 |
Vibrational spectroscopy for decoding cancer microbiota interactions: Current evidence and future perspective
|
Liu, Zhenhui
|
|
|
86 |
P3 |
p. 743-752
|
article
|
| 92 |
Vimentin and cytokeratin: Good alone, bad together
|
Kuburich, Nick A.
|
|
|
86 |
P3 |
p. 816-826
|
article
|
| 93 |
Virus-inspired strategies for cancer therapy
|
Ma, Xiao Yin
|
|
|
86 |
P3 |
p. 1143-1157
|
article
|
Journal description